Search research articles
Contact Us
Filters
Showing results (101-110 of 172) with videos related to
Page
of 18
Sort By:
Frontiers in Genetics
|
November 29, 2023
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
Jannat Pervin, Mohammad Asad, Shaolong Cao, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Strengthening Biomarker Research in Canadian Cancer Clinical Trials: A Pathology-Focused White Paper
David F Schaeffer, Jennifer Chan, Jason Morin, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
February 19, 2026
Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada
Ashley Paul, Shehara Mendis, Michael Diaz-Stewart, et al.
Cold Spring Harbor Molecular Case Studies
|
February 14, 2018
Molecular characterization of <i>ERBB2</i>-amplified colorectal cancer identifies potential mechanisms of resistance to targeted therapies: a report of two instructive cases
Daniel R Owen, Hui-Li Wong, Melika Bonakdar, et al.
The American Journal of Surgical Pathology
|
January 31, 2015
Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma
Kate O'Connor, Hector H Li-Chang, Steven E Kalloger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2020
Population-based Screening for <i>BRAF</i> <sup>V600E</sup> in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis
Jenny E Chu, Benny Johnson, Laveniya Kugathasan, et al.
Cell Death & Disease
|
March 18, 2020
PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response
Jie Ye, Anpei Huang, Haitao Wang, et al.
Human Pathology
|
April 29, 2014
ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts
Kimberly C Wiegand, Keiyan Sy, Steve E Kalloger, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
June 23, 2018
siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth
Shane P Duggan, Catherine Garry, Fiona M Behan, et al.
The Journal of Molecular Diagnostics : JMD
|
November 26, 2018
A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens
Miguel Alcaide, Matthew Cheung, Kevin Bushell, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 172) with videos related to
Sort By:
Page
of 18
Frontiers in Genetics
|
November 29, 2023
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
Jannat Pervin, Mohammad Asad, Shaolong Cao, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Strengthening Biomarker Research in Canadian Cancer Clinical Trials: A Pathology-Focused White Paper
David F Schaeffer, Jennifer Chan, Jason Morin, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
February 19, 2026
Comparison of Lanreotide and Octreotide LAR Use and Outcomes for Gastrointestinal Neuroendocrine Tumors in British Columbia, Canada
Ashley Paul, Shehara Mendis, Michael Diaz-Stewart, et al.
Cold Spring Harbor Molecular Case Studies
|
February 14, 2018
Molecular characterization of <i>ERBB2</i>-amplified colorectal cancer identifies potential mechanisms of resistance to targeted therapies: a report of two instructive cases
Daniel R Owen, Hui-Li Wong, Melika Bonakdar, et al.
The American Journal of Surgical Pathology
|
January 31, 2015
Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma
Kate O'Connor, Hector H Li-Chang, Steven E Kalloger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2020
Population-based Screening for <i>BRAF</i> <sup>V600E</sup> in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis
Jenny E Chu, Benny Johnson, Laveniya Kugathasan, et al.
Cell Death & Disease
|
March 18, 2020
PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response
Jie Ye, Anpei Huang, Haitao Wang, et al.
Human Pathology
|
April 29, 2014
ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts
Kimberly C Wiegand, Keiyan Sy, Steve E Kalloger, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
June 23, 2018
siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth
Shane P Duggan, Catherine Garry, Fiona M Behan, et al.
The Journal of Molecular Diagnostics : JMD
|
November 26, 2018
A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens
Miguel Alcaide, Matthew Cheung, Kevin Bushell, et al.
Page
of 18